Clariant AGXSWX:CLN +1.50%66 Debt-to-EBITDA is 9.58 as of Dec. 2025, which is 183% above its 10-year median of 3.38. GuruFocus rates XSWX:CLN with a GF Score™ of 66/100 and a GF Value™ of CHF9.90 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,232 Chemicals companies, Clariant AG ranks worse than 77.27% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Clariant AG's Debt-to-EBITDA or its related term are showing as below:
XSWX:CLN'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.4 Med: 3.38 Max: 5.42
Current: 5.42
During the past 13 years, the highest Debt-to-EBITDA Ratio of Clariant AG was 5.42. The lowest was 2.40. And the median was 3.38.
XSWX:CLN's Debt-to-EBITDA is ranked worse than 77.27% of 1232
companies
in the Chemicals industry
Industry Median: 2.16
vs XSWX:CLN: 5.42
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Clariant AG Debt-to-EBITDA Related Terms
Clariant AG Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Clariant AG's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:CLN vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Clariant AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariant AG Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Clariant AG's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Clariant AG's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Clariant AG (XSWX:CLN) has a Debt-to-EBITDA of 9.58 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Clariant AG. This is 183% above median its historical median of 3.38. Over the past decade, Clariant AG's Debt-to-EBITDA has ranged from 2.40 to 5.42. According to the industry distribution chart, Clariant AG ranks #952 out of 1232 companies in the Chemicals industry, placing it in the top 77.3%.
Is Clariant AG's Debt-to-EBITDA too high?
Clariant AG's current Debt-to-EBITDA of 9.58 is 183% above median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 2.40 to a high of 5.42. The Chemicals industry median Debt-to-EBITDA is 2.16. Clariant AG's value of 9.58 is 343.5% above this industry median. Based on the distribution chart, Clariant AG ranks #952 out of 1232 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Clariant AG has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clariant AG's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Clariant AG ranks #952 out of 1232 companies for Debt-to-EBITDA. This places Clariant AG in the lower half of its industry. The industry median Debt-to-EBITDA is 2.16. Clariant AG's value of 9.58 is 343.5% above this benchmark. Historically, Clariant AG's own Debt-to-EBITDA has ranged from 2.40 to 5.42 over the past decade. While the company's 10-year median is 3.38 vs. the industry median of 2.16, Clariant AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,232 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariant AG's current Debt-to-EBITDA of 9.58 is 343.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Clariant AG. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariant AG's current Debt-to-EBITDA is 9.58, which is 183% above median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariant AG stock overvalued right now?
Based on GuruFocus' analysis, Clariant AG (XSWX:CLN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF9.90, compared to a current price of CHF7.46 — trading 24.6% below its estimated fair value. The current Debt-to-EBITDA is 9.58, which is 183% above median its 10-year median of 3.38 and 343.5% above the Chemicals industry median of 2.16. Clariant AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Clariant AG (XSWX:CLN), the current Debt-to-EBITDA is 9.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariant AG (XSWX:CLN) Overvalued in 2026?
Based on GuruFocus' analysis, Clariant AG stock appears to be undervalued.
The current stock price of CHF7.46 is trading 24.6% below its estimated GF Value™ of CHF9.90.
GuruFocus considers Clariant AG to be Modestly Undervalued.
Key valuation signals for XSWX:CLN:
Debt-to-EBITDA: 9.58 (183% above median its 10-year median of 3.38)
GF Value™: CHF9.90 vs. price of CHF7.46 (24.6% below fair value)
Industry Position: 343.5% above the Chemicals median (#952 of 1232)
No single metric tells the full story. See the XSWX:CLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. It develops, manufactures, distributes, and sells a broad range of specialty chemicals, which play a key role in its customers' manufacturing and treatment processes or add value to their end products. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant's coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.
66GF Score
Get the complete analysis for XSWX:CLN
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLN has been successfully added to your 
